IRS2 and prostate carcinoma: However, in TCGA database analysis, IRS-2 gene mutations or gene amplification were observed in only a few percent of prostate cancer tissues [26,27,28], suggesting no correlation of IRS-2 gene expression with stages of prostate cancer.